SEC Form 4 · accession 0001055726-18-000037

INOVIO PHARMACEUTICALS, INC. · INO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — CFO

Period of report

Jul 9, 2018

Accepted (ET)

Jul 11, 2018 · 5:05 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001055726

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Jul 9, 2018	M	15,000	$4.24	A	97,088	D
Common Stock^F1	Jul 9, 2018	S	25,000	$4.43	D	72,088	D
Common Stock^F2	Jul 10, 2018	S	10,000	$4.45	D	62,088	D
Common Stock	holding	—	—		—	4,500	I	By Spouse

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Common Stock Option^F3,F4	$4.24	Jul 9, 2018	M	15,000	D	Jul 9, 2008	Jul 9, 2018	Common Stock	15,000	0	D

F1This transaction was executed in multiple trades at prices ranging from $4.42 to $4.43, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F2This transaction was executed in multiple trades at prices ranging from $4.43 to $4.46, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F3Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014.
F4The shares underlying this option vested and became exercisable on various dates between February 1, 2008 and February 1, 2011.